• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Planta medica

    Planta medica

    JournalISSN 0032-0943eISSN 1439-0221中科院 医学 4区

    年发文量

    研究主题

    论文(29233)

    排序
    1Study on Chenopodiastrum Hybridum's Anti-inflammatory and Antioxidant Effects in Zebrafish: Mechanism Against Ovarian Cancer
    Shuli Yang,Xueqin Feng,Peitong Wu,Duanduan Cheng,Jiaming Sun,Ruixin Lin

    Chenopodiastrum hybridum (CH) is an edible and folk medicinal plant, yet its efficacy and molecular mechanisms against ovarian cancer (OC) remain unclear, restricting its antitumor application. This study investigated the anti-OC effects and underlying mechanisms of CH via dose-effect weighted network pharmacology to provide experimental evidence for its clinical and medicinal development. This study determined the total flavonoid content of CH refined extract (CHRE) and assessed its inhibitory effect on OVCAR-3 cell proliferation. CHRE's antioxidant and anti-inflammatory activities were evaluated by free-radical scavenging ability and detection of ROS, NO, TNF-alpha, and IL-6 levels. Network pharmacology, molecular docking, and molecular dynamics simulations were applied to screen core targets and key pathways, with RT-qPCR verifying target gene expression. Flavonoid-rich CHRE significantly inhibited OVCAR-3 cell growth, exhibiting potent antioxidant and anti-inflammatory activities. The estrogen signaling pathway was identified as the core regulatory pathway. CH's key active compounds bound stably to the core targets (epidermal growth factor receptor [EGFR], ESR1, SRC, HSP90AA1, AKT1). RT-qPCR revealed downregulated mRNA levels of EGFR, AKT1, KDR, ESR1, and upregulated HSP90AA1 expression. CH suppresses OC proliferation by activating the estrogen signaling pathway to alleviate oxidative stress and inflammation. This study elucidates CH's anti-OC mechanism, offering valuable references for developing novel natural botanical drugs and auxiliary clinical therapies for OC.

    2026
    引用
    AI阅读
    加入学术空间
    2Evaluation of the Estrogenic Activity of Green and Fermented Aspalathus Linearis (rooibos) Extracts
    Sasha M. J. Marais, Glenn Averia,Lee-Maine L. Spies,Dalene De Beer,Ann Louw, Nicolette Verhoog

    The presence of plant polyphenols with pharmacophoric features similar to estrogens in an Aspalathus linearis (rooibos) extract warranted the in vitro evaluation of the estrogenic activity of green and fermented rooibos extracts ( n = 18). Whole-cell receptor binding assays demonstrated that compounds found within the rooibos extracts interact with both estrogen receptor (ER) subtypes, as they displaced radiolabeled E2. Although the extracts were much less potent than E2 in inducing agonism in promoter-reporter luciferase assays, most extracts displayed ER beta selectivity with higher efficacy via ER beta than via ER alpha. In contrast, extract potencies were generally comparable to ICI-182,780, an ER antagonist, in antagonizing E2, while their efficacies showed no ER-subtype selectivity. The preference of selected water extracts (WEs) to signal via ER beta was apparent in their inability to induce progesterone receptor ( PGR ) mRNA expression, an ER alpha-activated gene. Furthermore, the lack of PGR stimulation was consistent with Western blot assay results, where most WEs downregulated PR-B protein expression after shorter treatment times (2 or 4 h) and inhibited E2-induced PR-B protein expression after 24 or 48 h. To our knowledge, this study is the first to report that rooibos possesses antiestrogenic activity. This warrants further research for identifying the active compound(s) underlying the antiestrogenic effect, and for supporting the potential of rooibos as a therapeutic agent in diseases regulated by E2, such as ER-positive breast cancer.

    2026
    引用
    AI阅读
    加入学术空间
    3Development and Validation of an Optimized HPLC-DAD Method for Simultaneous Quantification of 14 Bioactive Compounds in Lonicerae
    Jinghua Li,Xizhe Sun,Xiaoyuan Peng, Hongjing Zhang, Ye Li

    Lonicerae Flos, an important traditional Chinese medicine, possesses a complex chemical composition and variable bioactive compound profiles, thereby necessitating reliable analytical methods for its quality control. In this study, a novel high-performance liquid chromatography-diode array detection method was developed for the simultaneous quantification of 14 bioactive compounds in Lonicerae Flos. A two-stage optimization strategy was employed, combining gradient elution refinement with response surface methodology based on a Box-Behnken design to systematically optimize injection volume, column temperature, and flow rate. Under the optimal conditions, baseline separation of all analytes was achieved within 25 min. The validated method exhibited excellent linearity (R & sup2; > 0.9990), sensitivity (LOQ <= 0.40 mu g/mL, LOD <= 0.12 mu g/mL), precision (intra- and inter-day RSD <= 3.59%), and recovery (97.03-102.62%), with satisfactory stability over 24 h. When applied to Lonicerae Flos samples from three geographical regions, the method revealed significant variations in chlorogenic acid, neochlorogenic acid, and 3,4-dicaffeoylquinic acid, highlighting its utility for geographical origin tracing and regional quality assessment. Specifically, chlorogenic acid showed a gradual increasing trend from Xiushan and Suiyang to Longhui, whereas neochlorogenic acid and 3,4-dicaffeoylquinic acid reached their highest levels in Longhui samples. Compared with existing methods, the proposed approach demonstrates superior performance with wider analyte coverage, improved separation efficiency, and simplified sample pretreatment. Accordingly, this work provides a practical tool to address the key challenges in the quality control of this medicinal plant, particularly the complex and variable profiles of bioactive constituents, thus supporting the standardization and quality evaluation of Lonicerae Flos.

    2026
    引用
    AI阅读
    加入学术空间
    4Ruscus Aculeatus Extract Inhibits Amyloid Beta Production and Upregulates the Active Form of ADAM10 in Human Neural Progenitor Cells
    Kenta Murata, Yoshiyuki Mizushina, Daisuke Izawa, Yasunori Matsui,Tomoko Wakabayashi,Tadafumi Hashimoto,Takeshi Iwatsubo, Yuji Matsushima

    Alzheimer's disease is characterized by the accumulation of cerebral amyloid beta (A beta) peptides, making the inhibition of A beta production a key therapeutic strategy. We screened a plant extract library for A beta 42 inhibitors using human neural progenitor cells and identified a Ruscus aculeatus extract as a potential candidate. Although rhizome extracts of R. aculeatus exhibit vasotonic, and anti-inflammatory properties, their effects on amyloid-beta precursor protein (APP) processing have not been investigated. We aimed to elucidate how R. aculeatus extract influences A beta production and its underlying mechanisms. R. aculeatus extract significantly reduced A beta 40 and A beta 42 production and the pathogenic A beta 42/A beta 40 ratio in both human neural progenitor (ReNcell VM) and mouse neuroblastoma (Neuro2a) cells in concentration-dependent manner. The extract enhanced non-amyloidogenic APP pathway processing, evidenced by increased levels of ADAM10 active form, soluble APP alpha and C-terminal fragment alpha levels. Despite increasing BACE1 protein levels, the extract reduced soluble APP beta production, suggesting inhibition of BACE1-mediated APP cleavage. RNA-seq analysis revealed Notch signaling pathway downregulation, implying gamma-secretase activity modulation. In conclusion, the R. aculeatus extract suppresses A beta production by modulating multiple APP processing pathways, primarily through enhancing non-amyloidogenic pathway via ADAM10 activation. By reducing amyloidogenic peptides levels, R. aculeatus extract may contribute to decreased amyloid plaques formation. These findings identify R. aculeatus extract as a modulator of APP metabolism.

    2026
    引用
    AI阅读
    加入学术空间
    5Potential Role of Unani Medicine in the Symptomatic Management of Sickle Cell Disease: A Mechanism-Based Narrative Review
    Tabasum Rouf, Iftikhar Ahmed, Mohd. Aadil Khan

    Sickle cell disease (SCD) is an inherited hemoglobinopathy characterised by chronic haemolytic anaemia, vaso-occlusive crisis, inflammation, oxidative stress and progressive multi-organ damage. Conventional therapies like hydroxyurea and haematopoietic stem cell transplantation have improved, but disease-related morbidity remains significant, particularly in resource-limited settings. Traditional medical systems may offer supportive approaches for symptom management and quality of life. Although SCD is not directly mentioned in classical Unani literature, many of its cardinal clinical features such as anaemia, fatigue, hepatosplenomegaly, pain, fever and nutritional deficiency have conceptual counterparts in unani descriptions of other diseases. This mechanism-based narrative review examines the hypothetical role of Unani medicine in the symptomatic management of SCD by incorporating traditional concepts with the modern biomedical knowledge. Special attention is paid to medicinal plants with antioxidant, anti-inflammatory, hepatoprotective, haematinic, analgesic and immunomodulatory activities. The review also discusses present gaps in knowledge and future research priorities for the evaluation of Unani interventions as adjunctive therapies in SCD management. No direct clinical evidence for Unani interventions in SCD currently exists; the Unani correlates proposed here are conceptual, and the supporting pharmacological data come largely from in vitro and non-SCD animal studies.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 29233 篇论文

    高被引作者

    作者引用发文
    Jl Mclaughlin81407
    Meyer B N80413
    Lb Jacobsen80141
    J.E. Putnam80141
    De Nichols80141
    N. R. Ferrigni80141
    Ikhlas Khan6022329
    H. P. T. Ammon454513
    Bauer, Rudolf4075194
    Arnold J Vlietinck371699

    高产作者

    作者引用发文
    Ikhlas Khan6022329
    Alexios-Leandros Skaltsounis3197230
    Shabana I. Khan3271230
    Bauer, Rudolf4075194
    Bharathi Avula2207191
    Matthias Hamburger3626173
    Luc Pieters3394142
    Zulfiqar Ali1683136
    YH Wang801135
    Hermann Stuppner1794128

    相关期刊

    Fitoterapia
    Natural product communications
    Phytochemistry Letters
    Journal of Natural Medicines
    Natural products and bioprospecting
    The natural products journal
    Phytochemistry Reviews
    Revista Brasileira de Farmacognosia
    Journal of Traditional and Complementary Medicine
    Chinese Herbal Medicines